The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events. (Q42207197)
Jump to navigation
Jump to search
scientific article published on 9 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events. |
scientific article published on 9 July 2014 |
Statements
The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events (English)
Mark B Lucera
Carisa A Tilton
Hongxia Mao
Caroline O Tabler
Aiman A Haqqani
Jonathan Karn